Group Knapp

Group Knapp

research group
Research Group Knapp graphic

L-MAC: Probing the STAT impact on homeostatic lung macrophage signatures

Network Contribution

Macrophages are prototypic resident immune cells that shape a range of effects, from safeguarding homeostasis to inflammation, based on their remarkable plasticity and ability to adjust quickly to changing environmental cues. A panel of transcription factors and epigenetic regulators in conjunction with STAT1/3/6 define the state of the resident macrophages. Recent advances in transcriptional and chromatin profiling have opened an entirely new avenue. This new avenue investigates the environmental cues that define tissue-specific macrophage profiles in health and their dynamics upon stress/disease. Our major goal is to analyse the role of STAT1/3 in the in vivo homeostatic signature of alveolar macrophages (AM) and to investigate the hierarchy of changes in acute perturbations of homeostasis (such as after birth). We shall determine the transcriptional profile (RNASeq) and enhancer landscape of healthy adult pulmonary macrophages by genome-wide mapping of selected histone marks and open chromatin (Chip-Seq, ATAC-Seq). Within the project part, we aim to derive a detailed map of transcriptional and enhancer landscapes of AMs, and insights into the role of STAT1/3. We will provide an excellent basis for understanding the memory potential and functional impact of perturbations and will open ways to develop drugs to modulate macrophage activity in inflammatory diseases.

Team

Photo of Sylvia Knapp, team leader

Sylvia Knapp

Team Leader

Sylvia Knapp

Sylvia Knapp studied medicine at the Medical University of Vienna and the Free University in Berlin DE and did her residency in Internal Medicine at the University Hospital of Vienna. She received her PhD from the University of Amsterdam NL and joined CeMM in 2006. In 2012 she was appointed Professor of Infection Biology at the Medical University, Vienna. Her research focuses on the innate immune and inflammatory responses to microbial infections with a strong translation to intensive care medicine.

photo of Asma Farhat

Asma Farhat

Team Member

Photo of Sophie Zahalka

Sophie Zahalka

Team Member

Contact

Laboratory of Infection Biology
Department of Medicine I
Medical University Vienna
Center for Molecular Medicine of the Austrian Academy of Sciences

Währinger Gürtel 18-20
1090 Vienna
Austria

sylvia.knapp@meduniwien.ac.at

Publications

SFB-F61 / F28 related publications - Group Knapp
Radwan*, M., Stiefvater*, R., Grunert, T., Sharif, O., Miller, I., Marchetti-Deschmann, M., Allmaier, G., Gemeiner, M., Knapp, S., Kovarik§, P., Mueller, M., and Strobl, B. (2010). *equal contribution §SFB member of the 1st funding period
Tyrosine kinase 2 controls IL-1beta production at the translational level.
J Immunol 185: 3544-3553. doi: 10.4049/jimmunol.0904000
Gratz, N., Hartweger, H., Matt, U., Kratochwill, F., Janos, M., Sigel, S., Drobits, B., Li, X.-D., Knapp, S., and Kovarik§, P. (2011). §SFB member of the 1st funding period
Type I Interferon Production Induced by Streptococcus pyogenes-Derived Nucleic Acids Is Required for Host Protection.
PLoS Pathog 7: e1001345. doi: 10.1371/journal.ppat.1001345
Laimer, D., Dolznig, H., Kollmann, K., Vesely, P.W., Schlederer, M., Merkel, O., Schiefer, A.-I., Hassler, M.R., Heider, S., Amenitsch, L., Thallinger, C., Staber, P.B., Simonitsch-Klupp, I., Artaker, M., Lagger, S., Pileri, S., Piccaluga, P.P., Valent, P., Messana, K., Landra, I., Weichhart, T., Knapp, S., Shehata, M., Todaro, M., Sexl, V., Höfler, G., Piva, R., Medico, E., Riggeri, B.A., Cheng, M., Eferl, R., Egger, G., Penninger, J.M., Jaeger, U., Moriggl, R., Inghirami, G., and Kenner, L. (2012).
PDGFR blockade is a rational and effective therapy for NPM-ALK–driven lymphomas.
Nat Med 18: 1699-1704. doi: 10.1038/nm.2966
Warszawska, J.M., Gawish, R., Sharif, O., Sigel, S., Doninger, B., Lakovits, K., Mesteri, I., Nairz, M., Boon, L., Spiel, A., Fuhrmann, V., Strobl, B., Mueller, M., Schenk, P., Weiss, G., and Knapp, S. (2013).
Lipocalin 2 deactivates macrophages and worsens pneumococcal pneumonia outcomes.
J Clin Invest 123: 3363-3372. doi: 10.1172/JCI67911
Castiglia, V., Piersigilli, A., Ebner, F., Janos, M., Goldmann, O., Dambock, U., Kroger, A., Weiss, S., Knapp, S., Jamieson, A.M., Kirschning, C., Kalinke, U., Strobl, B., Muller, M., Stoiber, D., Lienenklaus, S., and Kovarik, P. (2016).
Type I Interferon Signaling Prevents IL-1beta-Driven Lethal Systemic Hyperinflammation during Invasive Bacterial Infection of Soft Tissue.
Cell Host Microbe 19, 375-387
Maier, B.B., Hladik, A., Lakovits, K., Korosec, A., Martins, R., Kral, J.B., Mesteri, I., Strobl, B., Muller, M., Kalinke, U., Merad, M., and Knapp, S. (2016).
Type I interferon promotes alveolar epithelial type II cell survival during pulmonary S. pneumoniae infection and sterile lung injury in mice.
European journal of immunology 10.1002/eji.201546201
Martins, R., and Knapp, S. (2017).
Heme and hemolysis in innate immunity: adding insult to injury.
Curr Opin Immunol 50, 14-20
Cohen, M., Giladi, A., Gorki, A. D., Solodkin, D. G., Zada, M., Hladik, A., Miklosi, A., Salame, T. M., Halpern, K. B., David, E., Itzkovitz, S., Harkany, T., Knapp, S. and Amit, I.
Lung Single-Cell Signaling Interaction Map Reveals Basophil Role in Macrophage Imprinting
Cell. 2018 Sep 28. pii: S0092-8674(18)31181-4. doi: 10.1016/j.cell.2018.09.009
Watzenboeck, M.L., Drobits, B., Zahalka, S., Gorki, A.D., Farhat, A., Quattrone, F., Hladik, A., Lakovits, K., Richard, G.M., Lederer, T., Strobl, B., Versteeg, G.A., Boon, L., Starkl, P., and Knapp, S.
Lipocalin 2 modulates dendritic cell activity and shapes immunity to influenza in a microbiome dependent manner
PLoS Pathog 17, e1009487. Doi: 10.1371/journal.ppat.1009487
Gorki, A.D., Symmank, D., Zahalka, S., Lakovits, K., Hladik, A., Langer, B., Maurer, B., Sexl, V., Kain, R., and Knapp, S.
Murine ex vivo Cultured Alveolar Macrophages Provide a Novel Tool to Study Tissue-Resident Macrophage Behavior and Function
Am J Respir Cell Mol Biol 66, 64-75. Doi: 10.1165/rcmb.2021-0190OC
Esparza-Baquer, A., Labiano, I., Sharif, O., Agirre-Lizaso, A., Oakley, F., Rodrigues, P.M., Zhuravleva, E., O’Rourke, C.J., Hijona, E., Jimenez-Agueero, R., Riaño, I., Landa, A., La Casta, A., Zaki, M.Y.W., Munoz-Garrido, P., Azkargorta, M., Elortza, F., Vogel, A., Schabbauer, G., Aspichueta, P., Andersen, J.B., Knapp, S., Mann, D.A., Bujanda, L., Banales, J.M., and Perugorria, M.J.
TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms
Gut 70, 1345-1361. doi: 10.1136/gutjnl-2019-319227
Gawish, R., Starkl, P., Pimenov, L., Hladik, A., Lakovits, K., Oberndorfer, F., Cronin, S.J., Ohradanova-Repic, A., Wirnsberger, G., Agerer, B., Endler, L., Capraz, T., Perthold, J.W., Cikes, D., Koglgruber, R., Hagelkruys, A., Montserrat, N., Mirazimi, A., Boon, L., Stockinger, H., Bergthaler, A., Oostenbrink, C., Penninger, J.M., and Knapp, S.
ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFNγ-driven immunopathology
Elife 11, e74623. Doi: 10.7554/eLife.74623
Bayer, N., Hausman, B., Pandey, R.V., Deckert, F., Gail, L.M., Strobl, J., Pjevac, P., Krall, C., Unterluggauer, L., Redl, A., Bachmayr, V., Kleissl, L., Nehr, M., Kirkegaard, R., Makristathis, A., Watzenboeck, M.L., Nica, R., Staud, C., Hammerl, L., Wohlfarth, P., Ecker, R.C., Knapp, S., Rabitsch, W., Berry, D., and Stary, G.
Disturbances in microbial skin recolonization and cutaneous immune response following allogeneic stem cell transfer.
Doi: 10.1038/s41375-022-01712-z
Gawish, R., Maier, B., Obermayer, G., Watzenboeck, M.L., Gorki, A.D., Quattrone, F., Farhat, A., Lakovits, K., Hladik, A., Korosec, A., Alimohammadi, A., Mesteri, I., Oberndorfer, F., Oakley, F., Brain, J., Boon, L., Lang, I., Binder, C.J., and Knapp, S.
A neutrophil-B-cell axis impacts tissue damage control in a mouse model of intraabdominal bacterial infection via Cxcr4.
DOI 10.7554/eLife.78291
Gawish, R., Starkl, P., Pimenov, L., Hladik, A., Lakovits, K., Oberndorfer, F., Cronin, S.J., Ohradanova-Repic, A., Wirnsberger, G., Agerer, B., Endler, L., Capraz, T., Perthold, J.W., Cikes, D., Koglgruber, R., Hagelkruys, A., Montserrat, N., Mirazimi, A., Boon, L., Stockinger, H., Bergthaler, A., Oostenbrink, C., Penninger, J.M., and Knapp, S.
ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFN?-driven immunopathology.
DOI 10.7554/eLife.74623
Hendrikx, T., Porsch, F., Kiss, M.G., Rajcic, D., Papac-Mili?evi?, N., Hoebinger, C., Göderle, L., Hladik, A., Shaw, L.E., Horstmann, H., Knapp, S., Derdak, S., Bilban, M., Heintz, L., Krawczyk, M., Paternostro, R., Trauner, M., Farlik, M., Wolf, D., and Binder, C.J.
Soluble TREM2 levels reflect the recruitment and expansion of TREM2(+) macrophages that localize to fibrotic areas and limit NASH
DOI 10.1016/j.jhep.2022.06.004.
Zahalka, S., Starkl, P., Watzenboeck, M.L., Farhat, A., Radhouani, M., Deckert, F., Hladik, A., Lakovits, K., Oberndorfer, F., Lassnig, C., Strobl, B., Klavins, K., Matsushita, M., Sanin, D.E., Grzes, K.M., Pearce, E.J., Gorki, A., and Knapp, S.
Trained immunity of alveolar macrophages requires metabolic rewiring and type 1 interferon signaling.
DOI 10.1038/s41385-022-00528-5